INTRODUCTION {#s1}
============

The mammalian epidermis undergoes continuous self-renewal to repair damaged tissue and replace aged cells. A single layer of proliferative keratinocytes at the inner base of the epidermis gives rise to non-proliferative keratinocytes which renew the suprabasal (outer) layers, until they reach the outermost layer where they terminally differentiate and are shed \[[@R1]\].

In the human epidermis 14-3-3σ expression gradually increases along the axis of keratinocyte differentiation. Suppression of 14-3-3*σ* expression abrogates terminal keratinocyte differentiation and immortalizes human primary keratinocytes in cell culture \[[@R2], [@R3]\]. This suggests that elevated 14-3-3*σ* protein levels inhibit clonal expansion of cells within the epidermal basal layer and support keratinocyte differentiation.

The p63 protein is a master regulator of epidermal morphogenesis and is exclusively expressed in the basal cell layer. *p63*-null mice lack suprabasal layers and do not express differentiation markers \[[@R4]\]. ΔNp63α, an alternative p63 splice variant, transcriptionally represses *14-3-3σ* expression \[[@R5]\]. Thus, p63 and 14-3-3*σ* exercise opposite functions in the epidermis. In line with this scenario, it has been reported that 14-3-3σ binds to ΔNp63α upon DNA damage and sequesters ΔNp63α to the cytoplasm to facilitate its proteasomal degradation \[[@R6]\]. Thereby, an elevated 14-3-3*σ* expression could prevent expansion of the basal keratinocyte layer.

In addition, many studies have demonstrated that *14-3-3σ* expression is deregulated or lost in several types of human epithelial cancers \[[@R7], [@R8]\]. Silencing of the *14-3-3σ* gene by CpG-methylation also frequently occurs in breast cancer \[[@R9]\]. Hence, loss of 14-3-3σ could be a necessary step for the initiation and/or progression of epithelial tumorigenesis.

14-3-3σ has been characterized as a p53-target genes that is sufficient and necessary to mediate a G~2~/M-arrest after DNA damage \[[@R10], [@R11]\]. 14-3-3σ proteins only form homodimers and have a distinct repertoire of ligand interactions when compared to the six other 14-3-3 isoforms expressed in human and murine cells \[[@R12], [@R13]\]. 14-3-3σ dimers bind to a large number of ligands *via* phosphorylated serine/threonine residues and thereby presumably affect a plethora of cellular processes \[[@R14]\]. Numerous studies based on cellular analyses have implicated 14-3-3σ in the regulation of diverse processes, such as cell cycle progression, signaling, differentiation, apoptosis and metabolism \[[@R7], [@R15]--[@R17]\]. However, relatively few studies of the organismal function and relevance of 14-3-3σ employing genetically engineered mouse models have been reported. By studying a mammary epithelial-specific *14-3-3σ* knock-out mouse it was shown that *14-3-3σ*-deficient mammary epithelial cells lose their polarity and show increased proliferation \[[@R18]\]. Amplification and elevated expression of the *erbB2* proto-oncogene is associated with poor outcome in patients with breast cancer \[[@R19]\]. It has been shown that the Cre-mediated deletion of *14-3-3σ* in an *erbB2*-driven breast cancer mouse model enhances tumor initiation and metastases \[[@R20]\]. Additionally, ectopic *14-3-3σ* expression reduces the metastatic capacity of a human breast cancer cell line in a xenograft mouse model \[[@R21]\]. Therefore, 14-3-3σ shows tumor suppressive capacities *in vivo*.

The *repeated epilation* (*ER*) mouse model has been used multiple times for studying the role of 14-3-3σ in the epidermis. *ER* mutant mice harbor a single nucleotide insertion in the *14-3-3σ* gene causing a frame shift which leads to the expression of a C-terminally truncated 14-3-3σ protein that lacks the nuclear export signal and several phosphopeptide-binding residues \[[@R22], [@R23]\]. Homozygous *ER* mutant mice (*ER/ER*) die at birth as a result of respiratory stress \[[@R22]--[@R24]\]: The oral cavity is fused, limbs and tail are shortened, defined digits and nails are lacking. Their epidermis is strongly hyper-proliferative and thickened accompanied with failures in terminal differentiation. The hair follicles are underdeveloped and sparse. Heterozygous *ER* mutant mice *(+/ER*) are viable. However, at postnatal day 7 they display a hyper-proliferative epidermis, however not as pronounced as observed in *ER/ER* mutant mice at embryonic day E18.5. Furthermore, *+/ER* mutant mice show defects in hair shaft differentiation, resulting in destruction of the hair shaft and a cyclic hair loss \[[@R25]\]. Studies analyzing this hair defect showed that the heterozygous *ER*-mutation in *14-3-3σ* specifically affects the club hair retention \[[@R26]\] and causes severe defects in hair shaft differentiation during morphogenesis and abnormal cycling of the hair follicle stem cells in the bulge \[[@R25]\]. In addition, heterozygous *ER*-mice show an extensive hyper-proliferation of the epidermis followed by the development of multiple papillomas and squamous cell carcinoma at the age of 6 month \[[@R27]\]. *ER*-mice display increased levels of p63 in the epidermal suprabasal layers, suggesting that truncated 14-3-3σ fails to block the transcription of *TP63* which may contribute to hyper-proliferation of the epidermis \[[@R28]\]. In addition, Yap1, an essential factor of the Hippo pathway controlling organ size and tissue homeostasis \[[@R29]\], is expressed in the epidermal suprabasal layers of *ER*-mice \[[@R30]\]. In keratinocytes derived from *ER* mice truncated 14-3-3σ fails to bind and sequester Yap1 in the cytoplasm, suggesting that 14-3-3σ inhibits Yap1-dependent gene expression to control epidermal proliferation and differentiation.

To date the *in vivo* role of 14-3-3σ expression in epidermal homeostasis and tumorigenesis has been mainly inferred from results obtained with *ER*-mice. However, truncation of the 14-3-3σ protein in *ER*-mice may not be equivalent to deletion and therefore complete inactivation of 14-3-3σ function.

In this study we provide evidence that the *ER* phenotype may rather result from a gain of function mutation since we determined that 14-3-3σ deficiency does not affect homeostasis of normal epidermal tissues and does not result in perinatal lethality seen in *ER/ER* mice. Nonetheless, loss of 14-3-3σ sensitizes mice to chemically-induced skin carcinogenesis. Therefore, 14-3-3σ may indeed represent a mediator of tumor suppression in the skin.

RESULTS AND DISCUSSION {#s2}
======================

*14-3-3σ*-deficient mice display disorganized hair but lack obvious epidermal defects {#s2_1}
-------------------------------------------------------------------------------------

In order to analyze whether the reported phenotypes of *ER*-mice are caused by the expression of the truncated 14-3-3σ protein or are due to 14-3-3σ loss of function, we generated mice with a floxed *14-3-3σ* allele and inactivated the *14-3-3σ* gene in the germ-line by crossing these with *deleter-Cre* mice (see also [Supplemental Figure S1](#SD1){ref-type="supplementary-material"}). By further back-crossing we obtained *14-3-3σ*-deficient mice with an FVB background. FVB mice are prone to develop tumors of the skin when subjected to chemical carcinogenesis \[[@R31]\]. Mice with heterozygous (*14-3-3σ*^+/−^) and homozygous (*14-3-3σ*^−/−^) deletion of 14-3-3σ were viable, fertile and born at the normal Mendelian ratio, had a normal life-span and did not display an increase in tumor formation (data not shown). *14-3-3σ*^+/−^ mice were indistinguishable from their wild-type littermates. However, *14-3-3σ*^−/−^ mice showed a disorganized fur beginning around postnatal day 17 (Figure [1](#F1){ref-type="fig"}). Nonetheless, the histological analysis of skin from postnatal day 17 animals did not reveal obvious alterations in hair follicle density or hair shaft shape (Figure [2](#F2){ref-type="fig"}). Immunohistochemical detection of Loricrin indicated no difference in epidermal thickness either. Ki-67 staining did not reveal differences in proliferation of keratinocytes between the genotypes. Therefore, *14-3-3σ*^−/−^ mice and *14-3-3σ*^+/^*^ER^* mutant mice have at least one phenotype in common: a disorganized fur onwards from approximately 2 weeks after birth. However, other phenotypes characteristic for *14-3-3σ*^+/ER^ mice were not observed in *14-3-3σ*-deficient mice: the frequency of Ki-67-positive hair follicle matrix cells (Figure [2A](#F2){ref-type="fig"}) or basal epidermal cells (Figure [2B](#F2){ref-type="fig"}) was unchanged. Additionally, the number of hair follicles and the epidermal thickness showed no differences in 14-3-3σ^−/−^ tissues (Figure [2](#F2){ref-type="fig"}). Similar results were obtained after tissue specific *14-3-3σ* knockout in the epidermis of mice with a the C57BL/6J background ([Supplementary Figure S2A](#SD1){ref-type="supplementary-material"}). This suggested that the epidermal hyper-proliferation observed in *14-3-3σ*^+/ER^ mice is caused by the expression of the truncated 14-3-3σ protein, which acquired additional functions and presumably an altered ligand specificity, and not by the mere loss of 14-3-3σ function. Notably, p63 and YAP1 have been shown to functionally interact with the ER mutant of 14-3-3σ in murine epidermis \[[@R28], [@R30]\]. However, we could not detect an effect of *14-3-3σ* loss on the localization and expression level of p63 ([Supplemental Figure 2B](#SD1){ref-type="supplementary-material"}). In addition, we were unable to detect a functional or direct interaction or colocalization of 14-3-3σ with YAP1 in cells *ex vivo* (data not shown). Also YAP1 expression and localization in chemically induced skin papillomas was not affected by deletion of *14-3-3σ* in mice (data not shown). The expression of a truncated ER 14-3-3σ mutant may therefore indirectly promote the deregulation of p63 and YAP1, whereas complete loss of 14-3-3σ function does not affect the function and expression of p63 or YAP1. This divergence could, at least in part, explain the phenotypic differences between the *ER* mice and *14-3-3σ* knock-out mice.

![*14-3-3σ* knock-out mice show a disorganized fur from postnatal day 17 onwards\
Heterozygous *14-3-3σ* knock-out mice were intercrossed and pictures of the offspring with the indicated genotypes were taken at the indicated time-points.](oncotarget-07-46862-g001){#F1}

Unchanged frequency of spontaneous epidermal tumors in *14-3-3σ* deficient mice {#s2_2}
-------------------------------------------------------------------------------

To exclude the possibility that mice lacking *14-3-3σ* exhibit an attenuated epidermal hyper-proliferation phenotype similar to that of *14-3-3σ*^+/ER^ mice, we analyzed the long-term consequences of *14-3-3σ* deficiency in mice. *14-3-3σ*^+/+^, *14-3-3σ*^+/−^ and *14-3-3σ*^−/−^ (40 mice / genotype) mice were maintained for a prolonged time period (up to 32 months) and were inspected twice a week for the presence of neoplastic lesions or other pathologies. Mice with tumors larger than 2 cm in diameter or with other signs of illness were euthanized. Dead mice were analyzed by necropsy. Tumor burden of dead mice was recorded (Figure [3A](#F3){ref-type="fig"}). Time points of death were noted and used for calculation of the survival probability of each genotype (Figure [3A, 3B](#F3){ref-type="fig"}). No significant difference in survival between wild-type, heterozygous and knockout *14-3-3σ* mice was found. In addition, *14-3-3σ* knockout mice did not show a significantly increased risk of spontaneous tumor development (Figure [3A, 3B](#F3){ref-type="fig"}). Furthermore, the tumor burden was independent from the genotype (Figure [3A](#F3){ref-type="fig"}). These results show that *14-3-3σ* deficiency is not sufficient to initiate spontaneous skin carcinogenesis. Therefore, the development of multiple papillomas and squamous cell carcinomas observed in *14-3-3σ*^+/ER^ mice \[[@R27]\] is presumably not caused by the loss of 14-3-3σ function but rather by the expression of a truncated 14-3-3σ protein, which presumably acquired additional, non-physiologic properties.

![Comparison of back skin morphology in *14-3-3σ*^**+/+**^ and *14-3-3σ*^**−/−**^ mice\
Back skins from wild-type and *14-3-3σ* knock-out mice were resected at postnatal day 17, paraffin embedded, vertically sectioned and stained with haematoxilin/eosin (H&E, upper panels) or subjected to immunohistochemistry with 14-3-3σ, Ki-67, and Loricrin specific antibodies. **A.** Hair follicle density (scale bar = 300 μm) and hair shaft (HS) morphology (scale bar = 30 μm) are visible. The dashed line indicates the dermal papilla. Bar-chart: The average number of hair follicles per millimeter skin section was evaluated (*n* = 3). **B.** A higher magnification of the interfollicular epidermis and the underlying dermis is shown (scale bar = 10 μm). The dashed line indicates the border between epidermis and dermis. The Loricrin staining shows the outermost layer of the epidermis. Bar-chart: The average epidermal thickness was evaluated (*n* = 3).](oncotarget-07-46862-g002){#F2}

![Survival analysis of mice with varying *14-3-3σ* genotype\
**A.** Experimental groups (20 female and 20 male mice per group) and summary of results. **B.** Kaplan-Meier curve (*n* = 40) and p-values of the curve comparisons calculated using the GraphPad Prism5 software.](oncotarget-07-46862-g003){#F3}

*14-3-3σ* deficiency increases number and size of DMBA/TPA induced papillomata {#s2_3}
------------------------------------------------------------------------------

The *14-3-3σ* gene is frequently silenced in basal cell and squamous cell carcinoma \[[@R8], [@R32], [@R33]\]. Nevertheless, the pathophysiological relevance of *14-3-3σ* inactivation for epithelial skin cancer formation is largely unknown. In order to study the effect of *14-3-3σ* inactivation on the onset, frequency and progression of chemically-induced papillomas of the skin, which ultimately progress to squamous cell carcinomas (SCC), we employed a well-established two-stage model of chemical skin-carcinogenesis which is based on DMBA/TPA treatments \[[@R34]\]. The back skin of male wild-type and *14-3-3σ* knockout mice (7 to 9 weeks old) was treated in the pause phase of the hair cycle with a single dose of 7.12-dimethylbenz(a)anthracene (DMBA) for tumor initiation (Figure [4A](#F4){ref-type="fig"}). Two weeks later, both groups were treated twice a week with 12-O-tetradecanoylphorbol-13 acetate (TPA) for a total period of 20 weeks to achieve tumor promotion. The time points of tumor occurrence, number and size were quantified throughout the complete treatment period (Figure [4C-4F](#F4){ref-type="fig"}). After 20 weeks the back skin was resected (Figure [4B](#F4){ref-type="fig"}) and the number (4C) and size (4D) of tumors present in these specimen was determined. Subsequently, tumors were analyzed histologically (Figure [5](#F5){ref-type="fig"}). \~7 weeks after the first TPA administration the first skin tumors (≥1 mm diameter) occurred in both groups (Figure [4E](#F4){ref-type="fig"}). Over the subsequent 13 weeks of tumor promotion, the number of mice with tumors (Figure [4E](#F4){ref-type="fig"}) and the number of tumors per mouse (Figure [4F](#F4){ref-type="fig"}) increased significantly faster in *14-3-3σ* -deficient mice. By the end of the TPA treatments, 100% of the *14-3-3σ*-deficient and 89% of the wild-type mice had developed numerous tumors. 60% of the *14-3-3σ* deficient and only 11% of the wild-type mice had 16 or more tumors (Figure [4C](#F4){ref-type="fig"}). Counting of tumors with an area of ≥15mm^2^ revealed that *14-3-3σ* wild-type mice developed on average 2.8, whereas *14-3-3σ* knock-out mice displayed 5.5 papilloma of this size (Figure [4D](#F4){ref-type="fig"}). Taken together, *14-3-3σ*-deficient mice developed 1.8-fold more papillomas per mouse in total and 1.98-fold more larger tumors (≥15mm^2^) per mouse than wild-type mice (Figure [4F, 4D](#F4){ref-type="fig"}). Further examination revealed that all induced tumors from wild-type and *14-3-3σ* knock-out mice projected outwardly, with a cauliflower-like shape, which is a characteristic of benign papillomas (see example in Figure [5](#F5){ref-type="fig"}). Next we obtained tissues sections containing tumors of different sizes from wild-type and *14-3-3σ*-deficient mice and analyzed them microscopically after haematoxilin/eosin staining and by immunohistochemistry (Figure [5](#F5){ref-type="fig"}). Like we already had deduced from the external examination of the tumors (Figure [4B](#F4){ref-type="fig"}), inspection of the histological sections confirmed a tumor growth directed towards the outer side of the epidermis (Figure [5](#F5){ref-type="fig"}). The tumors resemble the architecture of normal skin with a basal layer, stratified squamous epithelium and an outer keratinized layer (Figure [5A](#F5){ref-type="fig"}). No invasion was observed (Figure [5B](#F5){ref-type="fig"}). Taken together our results show that *14-3-3σ* deficiency significantly increases the number and size of DMBA/TPA-induced papillomas. Thus, 14-3-3σ fulfills a tumor suppressive function *in vivo*, which presumably prevents the initiation and growth of epidermal tumors. This is in line with the timing of epigenetic inactivation of *14-3-3σ* in tumors, which has been described to occur in the early phases of tumor progression \[[@R35]\].

![Effect of *14-3-3σ*-deficiency on the number and size of DMBA/TPA-induced skin tumors\
**A.** *14-3-3σ*^+/+^; *n* = 9 and *14-3-3σ*^−/−^; *n* = 10 male mice were treated once with 100 nmol DMBA. After 2 weeks all mice were treated twice a week with 13.6 nmol TPA for 20 weeks. **B.** Overview of representative back skin resections (scale bar = 5 mm). **C.** Cumulative percentage of mice carrying the indicated numbers of tumors. **D.** Average numbers of large tumors (surface ≥ 15 mm^2^). Results are the mean ± s.e.m.; *p* = 0.041 by two-sided t test. **E.** Percentage of mice with detectable papillomas during the period of tumor promotion. **F.** Average number of tumors during the period of tumor promotion. Results are the mean ± s.e.m. with *p* = 0.0048 by Mann-Whitney *U* test.](oncotarget-07-46862-g004){#F4}

![Morphology of DMBA/TPA-induced epidermal tumors in mice with varying *14-3-3σ* genotype\
Skin sections containing papillomas from *14-3-3σ*^+/+^ and *14-3-3σ*^−/−^ were stained with haematoxilin/eosin and probed for Ki-67. The upper panel shows an overview of the whole papilloma/skin area (scale bar = 1 mm). The dashed boxes in the overview indicate the magnified areas of **a.** an apical tumor region, **b.** a tumor attachment site shown in the lower panels (scale bar = 100 μm).](oncotarget-07-46862-g005){#F5}

MATERIALS AND METHODS {#s3}
=====================

Generation and handling of mice {#s3_1}
-------------------------------

The detailed description of the generation of *14-3-3σ* deficient mice can be found in supplementary material and methods ([Figure S1](#SD1){ref-type="supplementary-material"}). *14-3-3σ*^−/−^ mice were transferred into an FVB background by backcrossing for at least 6 generations with FVB wild-type mice. For the experiments, FVB littermates of the genotypes *14-3-3σ*^+/+^, *14-3-3σ*^+/−^ and *14-3-3σ*^−/−^ were generated by intercrossing of FVB *14-3-3σ*^+/−^ mice. All mice were maintained in the animal facility at the Pathology Institute of the Ludwig-Maximilians-University Munich in individually ventilated cages (IVC). All animal experiments were approved by the Regierung von Oberbayern (AZ: 55.2-1-54-2532-11-13).

Genotyping PCR {#s3_2}
--------------

Genomic DNA was obtained by overnight digest of ear punches in lysis buffer (50 mM KCl, 1.5 mM MgCl~2~, 10 mM Tris pH8.5, 0.01% gelatin, 0.45% NP40, 0.45% Tween 20, 100 μg/ml proteinase K). PCR was performed for 35 cycles with an annealing temperature of 65°C. Primers for the detection of the *14-3-3σ* wild-type and floxed alleles (forward: 5′-CAC TAC CGT GGT CTT CCC TAA CTT GAT G-3′; reverse: 5′-TCC CAG GAA GCA GAT GGG ATT TCT GTC C-3′) and the *14-3-3σ* knock-out allele (reverse: 5′-AGG CAC TAT GCC CCT GCC TCA GAT-3′) were added in the same ratio to the reaction mix and PCR products were resolved on 2% agarose or 8% polyacrylamide gels. The PCR-products were 106 bp (wild-type allele), 159 bp (floxed allele), and 183 bp (*14-3-3σ* knock-out allele).

Determination of hair follicle numbers and epidermal thickness {#s3_3}
--------------------------------------------------------------

Dorsal skin from male *14-3-3σ*^+/+^ and *14-3-3σ*^−/−^ FVB littermates was dissected, fixed in 4% formalin, paraffin embedded, vertically sectioned at 5 μm distances, stained with haematoxilin and eosin (H&E), mounted and analyzed by light microscopy. Hair follicles were counted over an epidermis length of 1 mm from 3 individuals per genotype. In addition, the epidermal thickness was measured at 3 randomly chosen positions of the epidermis of 350 μm length using the AxioVison Rel4.8 software. Average numbers, standard deviation and significance were calculated using a Student\'s test (two-sided; *n* = 3).

Survival probability {#s3_4}
--------------------

40 mice (20 male, 20 female) per genotype (*14-3-3σ*^+/+^, *14-3-3σ*^+/−^, *14-3-3σ*^−/−^) with a FVB background were maintained and monitored over a period of more than 2 years. Moribund mice were euthanized and skin sections were analyzed immunohistochemically. Tumor burden \[No = 0, Yes = 1\] and age at death \[in days\] was documented. Survival probability was calculated according to Kaplan-Meier using GraphPad Prism5 software. Additionally, the percentage of mice with tumors was calculated.

Chemically-induced skin carcinogenesis {#s3_5}
--------------------------------------

The back skin of male *14-3-3σ*^+/+^ (*n* = 9) and *14-3-3σ*^−/−^ FVB (*n* = 10) littermates (7-9 weeks of age) was shaved 2 days prior to tumor initiation. Tumors were initiated with a single topical application of DMBA (Sigma-Aldrich, Munich, Germany, order no. 40567, 100 nmol in 50 μl methanol) to the back skins of the mice. Two weeks later, tumor promotion was achieved by topical application of TPA (Sigma-Aldrich, Munich, Germany, order no. P1585, 13.6 nmol in 200 μl acetone) twice weekly for 20 weeks. Tumor incidence (percentage of tumor-bearing mice) and multiplicity (papillomas per mouse) were recorded twice weekly throughout the experiment. Pictures of dissected back skin were taken and used to determine the sizes of papillomas \[mm^2^\] with the ImageJ software.

Immunohistochemistry {#s3_6}
--------------------

Tissues were fixed in 4% formalin and embedded in paraffin. 5 μm sections were prepared, deparaffinized in xylene and rehydrated in serial ethanol dilutions. Antigen retrieval was carried out by boiling in DAKO citrate buffer (pH 6.0) twice for 15 minutes in a microwave oven at 750 Watts. After quenching endogenous peroxidase activity by 10 min. exposure to 7.5% H~2~O~2~ solution, tissue sections were blocked in either 10% goat or rabbit serum, or 10% BSA for 30 min. at room temperature depending on the origin of the primary antibody. Primary antibodies were used at 1:20 dilution for anti-14-3-3σ (C-18, goat polyclonal anti-mouse, Santa Cruz), 1:500 for anti-Ki67 (D3B5, rabbit monoclonal anti-mouse, Cell Signaling), 1:500 for anti-Loricrin (AF62, rabbit polyclonal anti-mouse, Covance) and 1:100 for anti-p63 (4A4, Dako, supplementary data). Biotinylated secondary antibodies and streptavidin/HRP complexes were used according to the provided manual (Vectastain kit, Vector Labs). Sections were treated with DAB chromogenic substrate (DAKO), counterstained with haematoxilin and mounted in xylene-based mounting medium.

SUPPLEMENTARY MATERIAL {#s5}
======================
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ER

:   repeated epilation

DMBA

:   7.12-dimethylbenz(a)anthracene

TPA

:   12-O-tetradecanoylphorbol-13 acetate
